News Releases

2019-04/18
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption(N Engl J Med 2019; 380:1535-1545)
1
2019-04/18
United BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicine
2
2019-04/18
How an Experimental Injection Could Revolutionize HIV Treatment
3
2019-04/18
Novel antibody may suppress HIV for up to four months
4
2019-04/17
Monoclonal antibody demonstrates ‘unprecedented’ virologic suppression in HIV study
5
2019-04/17
Weekly Infusion May Be Effective, Easier HIV Therapy
6
2018-12/06
United BioPharma obtained Taiwan FDA approval for conducting phase I clinical trial of its UB21 product, a third generation monoclonal anti IgE antibody
7
2018-12/15
Received approval from TFDA for UB-421 phase II , proof of concept trial of HIV functional cure
8
2018-10/15
Filed IND for UB-421 phase II, proof of concept trial of HIV functional cure to TFDA
9
2019-04/18
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption(N Engl J Med 2019; 380:1535-1545)
1
2019-04/18
United BioPharma Announces Publication of Breakthrough HIV Clinical Trial Data in the New England Journal of Medicine
2
2019-04/18
How an Experimental Injection Could Revolutionize HIV Treatment
3
2019-04/18
Novel antibody may suppress HIV for up to four months
4
2019-04/17
Monoclonal antibody demonstrates ‘unprecedented’ virologic suppression in HIV study
5
2019-04/17
Weekly Infusion May Be Effective, Easier HIV Therapy
6
2018-12/06
United BioPharma obtained Taiwan FDA approval for conducting phase I clinical trial of its UB21 product, a third generation monoclonal anti IgE antibody
7
2018-12/15
Received approval from TFDA for UB-421 phase II , proof of concept trial of HIV functional cure
8
2018-10/15
Filed IND for UB-421 phase II, proof of concept trial of HIV functional cure to TFDA
9